Atlas Trials

PEG (Polyethylene Glycol)Versus Lactulose For Treatment Of Overt Hepatic Encephalopathy

Clinical trial NCT03100513 · UNKNOWN

Trial details

NCT number
NCT03100513
Sponsor
Sherief Abd-Elsalam
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatic Encephalopathy
Start date
2017-03-11
Primary completion
2019-10-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.